Innovative robot-assisted gastrectomy utilizing 5G communication technology for gastric cancer patients

NewsGuard 100/100 Score

Globally, gastric cancer is the fifth most common malignancy and the fourth leading cause of cancer-related death, with China bearing nearly half of these cases. These figures underscore an urgent need for innovative solutions in the field, particularly given the huge disparities in access to diagnostic and treatment resources in remote and underserved areas.

In a study ( recently published in the KeAi journal Intelligent Surgery, a team of researchers from China reported the first robot-assisted remote radical distal gastrectomy performed using 5G communication technology. While previous studies have demonstrated the effectiveness of 5G technology in various fields, such as urology and orthopedics, its application in gastric surgery has so far been limited to preclinical trials on animals and cadavers.

The novel procedure was conducted on a 51-year-old patient diagnosed with stage T2N0M0 gastric cancer, utilizing the domestically developed Tuomai four-arm laparoscopic robotic surgery system. Notable results include minimal intraoperative delays and no packet loss, highlighting the potential of 5G technology to advance remote surgical procedures. The patient's quick recovery without complications affirmed the procedure's safety and effectiveness.

This is the initial clinical experience of this new technology, and preliminarily verified the feasibility and safety. We believe that the findings from this study lay a solid foundation for the future of telemedicine in treating patients with gastric cancer."

Professor Zhao, lead researcher of the study

Journal reference:

Guo, H., et al. (2024). Pioneering case: Robot-assisted remote radical distal gastrectomy for gastric cancer based on 5G communication technology. Intelligent


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cancer projections show increased prostate cases by 25% in 2050, despite prevention efforts